Connecting phosphorylation events to kinases and phosphatases is key to understanding the molecular organization and signaling dynamics of networks. We have generated a validated set of transgenic RNA-interference reagents for knockdown and characterization of all protein kinases and phosphatases present during early Drosophila melanogaster development. These genetic tools enable collection of sufficient quantities of embryos depleted of single gene products for proteomics. As a demonstration of an application of the collection, we have used multiplexed isobaric labeling for quantitative proteomics to derive global phosphorylation signatures associated with kinase-depleted embryos to systematically link phosphosites with relevant kinases. We demonstrate how this strategy uncovers kinase consensus motifs and prioritizes phosphoproteins for kinase target validation. We validate this approach by providing auxiliary evidence for Wee kinase-directed regulation of the chromatin regulator Stonewall. Further, we show how correlative phosphorylation at the site level can indicate function, as exemplified by Sterile20-like kinase-dependent regulation of Stat92E.
INTRODUCTION
Despite the ease with which we can identify protein phosphorylation, in the vast majority of cases, the protein kinase(s) or phosphatase(s) responsible for controlling any particular phosphorylation event is unknown. We sought to develop a proteomic strategy to easily and systematically screen for candidate protein kinase and phosphatase substrates in Drosophila melanogaster embryos, with the goal of identifying specific residues that these enzymes target in the context of development. D. melanogaster is an ideal model for the dissection of signaling mechanisms, as the majority of transcription in the embryo occurs after the midblastula transition (MBT), and thus, transcriptional feedback has relatively no impact on the phosphoproteome in early embryos. Additionally, since the embryo is a syncytium prior to cellularization at the MBT, distortions in phosphosite measurements due to contributions from multiple cell types can be avoided. However, acquiring sufficient material from mutant embryos for proteomic studies is a challenge. The classical technique to generate maternally deficient embryos-relying on the production of germline clones using the flippase (FLP) recombinase-mediated dominant female sterile technique (Chou and Perrimon, 1996) is labor intensive, as it involves the construction of complex genotypes. Moreover, background mutations on the FLP-recognition-target-bearing chromosome can confound phenotype interpretation, and the approach does not typically yield enough material for proteomic studies.
Here, we describe how we have used genetic manipulation by transgenic RNA interference (RNAi) to derive sufficient quantities of embryos for phosphoproteomic analyses. RNAi is a wellfounded method to analyze gene function in D. melanogaster (Perrimon et al., 2010) , but the efficacy of RNAi during early embryogenesis has only recently been improved to enable robust gene knockdown during this developmental stage (Ni et al., 2011) . By using the Gal4/UAS system (Brand and Perrimon, 1993 ) to temporally and spatially restrict expression of RNAi reagents, we confined protein kinase and phosphatase knockdown specifically to the germline. Using this strategy, we were able to query maternal gene function without affecting the viability of the animal, since an intact germline is dispensable for organismal development. We generated and validated a transgenic RNAi library that targets all protein kinases and phosphatases expressed in the D. melanogaster germline. Through rigorous characterization of our collection, we uncovered maternal-effect genes and verified previously implicated kinases and phosphatases in early D. melanogaster development. Furthermore, we systematically monitored global phosphoproteome alterations in kinase-deficient embryos for the purpose of illustrating how the method can generate lists of candidate kinase substrates. The approach illuminated kinase-dependent signaling and permitted the unbiased prediction of kinase consensus motifs that match kinase specificities previously characterized in vitro. As anticipated, the strategy identified downregulated phosphoproteins that include bona fide kinase substrates of the depleted kinase and an extensive list of candidate kinase-targeted substrates and phosphosites. We further establish that two phosphosites consistently responding in the same direction (positive correlation) or the opposite direction (negative correlation) in different genetic contexts can illuminate phosphosite functionality. Given the extensive similarity between human and D. melanogaster kinases, and the conservation of functional phosphorylation (Gnad et al., 2010; Landry et al., 2009) , we anticipate that insight gained from our data and analyses will inform future mammalian studies.
RESULTS

Compilation of the Maternally Inherited Protein Kinome and Phosphatasome
The D. melanogaster genome encodes 32 tyrosine kinases, 237 serine/threonine kinases, and 112 protein phosphatases (Manning et al., 2002; Morrison et al., 2000) . To systematically link protein phosphorylation sites with their cognate kinases and phosphatases in D. melanogaster, we first identified the complement of kinase and phosphatase messenger RNAs (mRNAs) that are deposited maternally and contribute to the early zygote by analyzing developmental time course RNA sequencing (RNA-seq) data (Graveley et al., 2011) . Using an RPKM (reads per kilobase of exon model per million mapped reads) cutoff of 3, determined by comparison to real-time quantitative PCR (qPCR) analysis of staged embryos (Hu et al., 2013b) , we determined that 201 protein-kinase-encoding transcripts and 76 protein phosphatase-encoding transcripts (Figure 1A ; Table S1 available online) are present during the first 4 hr of embryogenesis (stages 1-8). This accounts for 75% and 68% of all protein kinases and phosphatases, respectively, encoded in the D. melanogaster genome ( Figure 1A ). We independently verified the presence of these transcripts by realtime qPCR (Figure 2A ) but detected only 172 kinases and 67 phosphatases in 2-hr-old embryos (stages 1-4) at the protein level based on peptide MS1 feature intensities from shotgun mass spectrometry ( Figure 1A ). Most kinases and phosphatases we identified as transcripts were reliably detected as protein. We found that, for only 28 kinases and 9 phosphatases where mRNA was identified, the corresponding protein at the appropriate time interval was not detected (Table S1 ). Thus, mRNA detection was generally a good predictor of protein presence. However, when considering levels rather than identity, we found no correlation between mRNA and protein ( Figure S1 ), similar to observations from large-scale studies in Schizosaccharomyces pombe (Marguerat et al., 2012) . Using a stringent criterion of conservation (i.e., at least three independent prediction tools support an orthologous gene-pair relationship; Hu et al., 2013a), we found that nearly all protein kinases and phosphatases expressed during early D. melanogaster development are conserved to human (Figures 1B and 1C;  Table S1 ). On the contrary, conservation to yeast is far more limited.
Generation and Validation of the Transgenic shRNA Collection Targeting Kinases and Phosphatases
We previously demonstrated the utility of short hairpin RNAs RNA (dsRNA) transgenic lines indicates that screening of shRNA lines triples the frequency of RNAi-derived germline phenotypes (Yan et al., 2014) , generally due to higher expression of shRNAs in the germline (Ni et al., 2011) . Having characterized the requirements for efficient gene knockdown during oogenesis, we sought to generate a complete and validated set of shRNA-expressing transgenic lines capable of targeting protein kinases and phosphatases that are contributed maternally to the developing embryo. To induce shRNA expression specifically in the female germline using the Gal4-UAS system, we crossed females heterozygous for a UAS shRNA and either MTD-Gal4 (a line bearing three copies of Gal4 expressed sequentially throughout oogenesis; Petrella et al., 2007) or tub-Gal4 (a line bearing two insertions of Gal4 expressed from a maternal tubulin promoter during midand late oogenesis; Staller et al., 2013) to shRNA-bearing males in order to recover fertilized eggs. We analyzed more than 450 transgenic lines expressing shRNAs targeting protein kinases and phosphatases (Table S2) . We were unable to recover eggs from $12% of the lines crossed to MTD-Gal4, accounting for 46 kinases and 6 phosphatases and implying that these genes are required for early oogenesis. For those lines from which we could recover eggs, we determined by real-time qPCR (A) Plotted is the average remaining transcript level for individual protein kinases and phosphatases targeted by a specific shRNA, relative to a shRNAtargeting EGFP, as assessed by real-time qPCR. Three reference genes were used for normalization. Approximately 12% of the lines could not be analyzed, since germline knockdown of these genes induced female sterility (no eggs). Indicated in red are lines that generated phenotypes. (B) Lysate from 0-4 hr embryos was subjected to immunoblotting, and levels of the corresponding kinase or phosphatase were assessed relative to tubulin. Indicated below the immunoblots is the extent of knockdown determined by RT-qPCR, achieved for the corresponding shRNA. See also Figure S2 . transgenic lines we analyzed generated greater than 60% knockdown of corresponding kinase or phosphatase mRNA levels in 0-4 hr embryos, relative to a control shRNA targeting enhanced green fluorescent protein (EGFP) (Figures 2A and S2A) . We observed excellent correlation between knockdown at the mRNA and protein level, which was assessed by comparing mRNA levels assessed by real-time qPCR to immunoblots of a subset of proteins for which antibodies were available ( Figure 2B ). We were interested in determining the number of transgenic lines that would need to be considered to observe at least one achieving >60% knockdown of the targeted transcript. We found that, when considering two unique shRNAs targeting the same gene product, this occurs at a frequency of 86% (N = 81 pairs) ( Figure S2B ). These data suggest that generating two independent shRNA lines is usually sufficient for obtaining at least one line that confers adequate knockdown. Interestingly, many cases of poor knockdown can be attributed to shRNA targeting design. Specifically, our data indicate that shRNAs targeting the transcript coding sequence (CDS) are more effective at knockdown than those targeting 3 0 untranslated regions (UTRs) ( Figure S2C ), possibly reflecting inaccuracies in UTR annotation (Hu et al., 2013b) .
Notably, we found no correlation between the degree of knockdown and the level of corresponding transcript in untreated early embryos ( Figure S2D ). Furthermore, our data exhibit no bias toward the concentration of recovered RNA or the date of sample collection ( Figures S2E and S2F ). Taken together, our collection consists of at least one transgenic line that provides a minimum of 60% knockdown for each maternally inherited protein kinase and phosphatase.
Assessment of Transgenic shRNA Collection Phenotypes
Our shRNA-directed knockdown strategy recapitulated many documented maternal-effect phenotypes ( Figure 3A 
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Surveying Phosphorylation Networks in Drosophila expected, we observed anterior-posterior terminal defects following the disruption of terminal signaling, such as that resulting from knockdown of the receptor tyrosine kinase torso, the SHP2 phosphatase ortholog corkscrew, or the downstream kinase suppressor of ras, ksr ( Figure 3A) . Altogether, we observed maternal-effect phenotypes for $18% of lines that achieved 60% or greater knockdown ( Figure 3B ; Table S2) , representing approximately 33% and 18%, respectively, of protein kinases and phosphatases expressed during early embryogenesis. Of those protein kinases and phosphatases for which a maternaleffect phenotype has been reported, we observed the same qualitative phenotype as that described in the literature approximately 74% of the time (26/35 genes considering germline clone-derived embryos; 2/3 considering embryos derived from homozygous mutant mothers; Table S3A ). Anomalies can likely be attributed to: (1) weak hypomorphic alleles generating a less severe phenotype than extensive knockdown; (2) insufficient knockdown by an shRNA to produce phenotypes generated by strong or null mutant alleles; or, (3) in the case of embryos derived from mutant mothers, an effect resulting from mutant somatic follicular cells. Despite the fact that protein kinases and phosphatases are among the best characterized classes of genes, we uncovered unappreciated phenotypes for approximately 40 of these enzymes, implying roles in oogenesis and early embryogenesis. Further, knockdown of an additional 12 predicted kinases and phosphatases resulted in oogenesis and maternal-effect phenotypes, warranting more extensive characterization. A searchable interface to query genes for individual transgenic lines, a description of their knockdown and embryonic phenotypes, and photos of cuticle preparations for those with maternal-effect phenotypes can be found at http://www. flyrnai.org/RSVP.html. We addressed the possibility and frequency of shRNAs generating phenotypes as a result of off-target effects (OTEs) in two ways. First, we compared pairs of unique shRNAs targeting the same gene for similar phenotypes. Comparing 24 efficient targeting pairs, we found that 80% produced the same qualitative phenotype ( Figure 3C ; Table S3B ). Four of the six cases of a differential phenotype can be explained by the extent of knockdown. Second, we established transgenic lines expressing ''C911'' versions of a targeting shRNA: a near-identical shRNA but with complementary nucleotides situated at positions 9-11. The mismatched shRNA precludes on-target binding while maintaining off-target binding since antisense and sense seed sequences remain intact (Buehler et al., 2012) . Consistent with phenotypes resulting from on-targeting specificity provided by perfect complementary of the shRNA, we eliminated phenotypes resulting from expression of 16 unique shRNAs by mutating the central three nucleotides of the shRNA. We verified by real-time qPCR that mutation of these three residues eliminated knockdown of corresponding kinase transcripts that the shRNA originally targeted (data not shown). Thus, we conclude that the prevalence of OTEs affecting early embryogenesis is minimal with the shRNA targeting strategy.
A Resource Providing Accessibility for Proteomic Analyses and Kinase Characterization
Our current reagents for germline-specific RNAi make it relatively easy to obtain large numbers of eggs depleted of a single gene product. This allowed us to perform quantitative proteomic experiments to measure the global effect of each perturbation on the phosphoproteome ( Figure 4A ). We anticipated that a relative quantitative and global assessment of altered phosphorylation in protein kinase-deficient embryonic extracts could provide a list of putative protein kinase-substrate (KS) and phosphosite matches. We also reasoned that phosphorylation signatures could also be used to predict roles for protein kinases and phosphatases in specific biological processes and reveal functional redundancy.
We initially assessed the reproducibility of phosphoproteomic profiles generated from analysis of separate populations of control shRNA embryos. We utilized mass spectrometry and an isobaric labeling strategy (see the Protocol) that enables multiplexing and relative quantification between samples (see Supplemental Experimental Procedures). Since $700 embryos constitute the amount of material ($1 mg protein) we chemically label, the phosphoproteomic profile is a representative average of phosphorylation in this population. Amine-reactive TMT Isobaric Mass Tags, identical in mass but differing in their isotopic distribution of atoms, permit the simultaneous spectral identification of unique reporter ions generated from MS2-based fragmentation of each tag from labeled peptides. We compared TMT reporter ion intensities and phosphopeptide identities from three TMT-labeled control shRNA embryo populations in two independent experiments (Table S4) . When considering those phosphopeptides in the same multiplex experiment (10,166 phosphopeptides for one experiment and 8,032 for the other; see Supplemental Experimental Procedures for normalization and specific criteria), we generally identify the same phosphopeptide in all three biological replicates ($99% of the time). In the two independent experiments, we observed phosphopeptide levels deviating an average of 7% ( Figure S3A ) and 29% ( Figure S3B ) between three biological replicates. This indicates that variability in factors such as peptide labeling and embryo collection has little influence on our ability to consistently detect the majority of phosphopeptides.
Given the reproducibility between control shRNA replicates, we extended our phosphoproteomic examination to embryos derived from females expressing efficient shRNAs (as determined by real-time qPCR) targeting 19 different protein kinases ( Figure 4B ). We were able to quantify nearly 8,500 unique phosphosites among 19 deficient kinase samples (Tables S5A-S5D ). The number of unique phosphosites we quantified between experiments, ranging from 6,331 to 2,448, was based on the number of unique phosphopeptides identified per experiment, ranging between 22,942 and 12,201. Notably, 1,140 phosphosites were quantified in all 19 kinase knockdown conditions, 1,343 in ten kinase knockdown conditions, and 4,358 in five kinase knockdown conditions. The majority of phosphopeptides (C) Phosphoproteins with two or more downregulated phosphosites (>1.5-fold) were classified into four types based on the directionality of change of the majority of identified phosphosites for the same protein: type 1, most identified phosphosites do not change; type 2, most identified phosphosites are downregulated; type 3, all identified phosphosites are downregulated; and type 4, most identified phosphosites are upregulated. See also Figures S3 and S4 .
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Surveying Phosphorylation Networks in Drosophila in each kinase-deficient sample were unchanging in abundance relative to the same control shRNA included in each multiplex experiment. In terms of candidate kinase-targeted phosphosites, either direct or indirect, we consider those downregulated sites with changes of 1.5-fold or greater in kinase-deficient embryos relative to control embryos, since observed phosphopeptides for seven shRNA-targeted kinases-Wee, Tao, Atg1, Gilgamesh (Gish), Lkb1, Grapes (Grp), and Sterile20-like kinase (Slik)-minimally met this criterion (2.27-fold, 1.95-fold, 1.69-fold, 2.24-fold, 2.68-fold, 1.98-fold, and 2.1-fold, respectively) in corresponding kinase-deficient embryos ( Figure S4A ). We did not detect phosphopeptides for the other 12 shRNA-targeted kinases. Moreover, changes in the phosphorylation of known substrates of shRNA-targeted kinases approach this value; for instance, Histone H3, Med13, and Stat92E (downregulated 2.2-fold, 1.8-fold, and 2.4-fold, respectively) in Cdk8-deficient embryos and Cdk1, Klp61F, and Hsp83 (downregulated 1.4-fold, 2.1-fold, and 1.7-fold, respectively) in wee-deficient embryos. Indeed, for a third of the D. melanogaster orthologs of literature-curated Cdk8 substrates in yeast (Sharifpoor et al., 2011) we identified, one or more respective phosphopeptides were downregulated >1.5-fold in Cdk8-deficient embryos (Table  S5E) . Using this criterion, the number of downregulated phosphosites in kinase-deficient profiles ranged from 22 (Bub1-deficient embryos) to 752 (Cdk8-deficient embryos) (Table S5 ). Of note, while our Bub1-targeting shRNA generated efficient knockdown (99% knockdown), Bub1-deficient embryos exhibited no morphological or hatch rate defects (Table S2) , consistent with minimal effects on the phosphoproteome. Conversely, knockdown of Cdk8, a cyclin-dependent kinase influencing transcription and cell cycle progression (Szilagyi and Gustafsson, 2013) , resulted in dramatic and penetrant morphological and hatch rate phenotypes, consistent with extensive modulation of the observed phosphoproteome. We speculate that among those phosphosites downregulated >1.5-fold in the 19 kinase-deficient contexts we surveyed are sites directly targeted by the corresponding depleted kinase(s), as well as indirect targets altered downstream of the manipulated kinase. For instance, in the case of gish-deficient embryos, we observed enrichment of downregulated phosphorylation of proteins involved in Hedgehog (Hh) and Wnt/Wingless (Wg) pathways (Table S5B) , consistent with a role for Gish in mediating Hh and Wg signaling (Davidson et al., 2005; Hummel et al., 2002) . These data indicate that, by monitoring changes in the phosphoproteome, one can effectively screen for candidate substrates and alterations in signaling downstream of the targeted kinase. However, further scrutiny of any altered phosphosite is required to prove a KS relationship, as we demonstrate later.
In order to distinguish genuine kinase targets from phosphosite alterations due to protein instability, we classified phosphoproteins with two or more downregulated phosphosites (>1.5-fold) into five categories based on the directionality of change of the majority of identified phosphosites for each individual protein: type 1, the majority of phosphosites do not change; type 2, the majority of phosphosites are downregulated; type 3, all phosphosites are downregulated; type 4, most phosphosites are upregulated; and type 5, indistinguishable due to an equal distribution of unchanged, upregulated, or downregulated phosphosites ( Figure 4C ). In considering at least two phosphosites, we increase the probability that the corresponding phosphoprotein is indeed subjected to degradation and not merely reduced in phosphorylation at a single site. Type 1 and type 4 phosphoproteins are those for which we can reasonably discount the possibility of protein degradation as a mechanism of downregulated phosphorylation and, thus, are considered high-priority candidates for phosphorylation by the respective kinase. The observed downregulation of type 3 phosphoproteins, on the other hand, can be explained by indirect mechanisms leading to protein degradation, such as altered proteinprotein interactions or phosphorylation-mediated degradation. Although most phosphoproteins in our data set are of type 1 (Figure 4C) , type 3 phosphoproteins account for $20%, on average, of those proteins with two or more downregulated phosphosites in each kinase depletion condition. This percentage is in line with previous reports that protein expression changes account for less than 25% of differential phosphorylation (Bodenmiller et al., 2010; Wu et al., 2011) . We scrutinized respective transcripts for type 2 and type 3 phosphoproteins in order to identify and filter our data set of potential OTEs due to partial complementarity of the targeting shRNA to unintended transcripts. By comparison to the frequency of partial complementarity of each targeting shRNA (seven-nucleotide match to seed) to the early embryonic transcriptome, we find a relatively weak probability for partial complementarity of our targeting shRNAs to 3 0 UTRs or transcripts of type 2 phosphoproteins (see Supplemental Information) . This probability declines when considering type 3 phosphoproteins, indicating that off-targets are not enriched in our data set and are therefore unlikely to explain alterations observed in our analyses. To further substantiate this assumption, we proceeded to knock down respective transcripts for type 3 phosphoproteins with the best matches to each corresponding kinase shRNA seed. Germline-specific knockdown of ten candidate off-targets predicted for six kinase-targeting shRNAs failed to generate phenotypes that could explain specific phenotypes attributed to the corresponding kinase shRNA (see Supplemental Information).
Extracting Patterns in Phosphorylation Data Sets to Find KS Relationships
We speculated that we might be able to extract KS relationships and insight into signaling pathway connectivity from our phosphorylation data set as a whole by examining patterns in phosphoalterations among kinase-deficient contexts. For instance, since most kinases are activated by phosphorylation, correlative phosphorylation events observed between kinases and other proteins could be indicative of KS relationships. On the other hand, anticorrelative phosphorylation could be additionally informative; inhibitory phosphorylation of a kinase would always be out of phase with phosphorylation of that kinase's respective targets. To explore such possibilities, we surveyed correlations in phosphorylation changes (>1.5-fold cutoff relative to a control shRNA) between identified phosphosite pairs among our kinase-deficient conditions (447,585 correlative pairs involving 2,058 phosphosites; Table S6A ). When considering phosphosite pairs exhibiting positive or negative correlation in at least four kinase-deficient conditions (25,077 correlative pairs), we find enrichment for authentic KS pairs ( Figure 5A ), derived from 133,051 D. melanogaster KS pairs (Table S6B ) predicted from
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Surveying Phosphorylation Networks in Drosophila 179 conserved human kinase phosphorylation motifs by NetPhorest (Miller et al., 2008) and from mapping of 517 gold standard KS pairs in yeast (Sharifpoor et al., 2011) to D. melanogaster. Enrichment for authentic KS pairs still exists when considering phosphosite pairs correlating in only two or three kinase-deficient conditions ( Figure S5A ). Strikingly, we also find enrichment for correlative phosphorylation among components of the same protein complex (p = 7.5 3 10 À157 ), further substantiating how this phenomenon can be exploited to identify functionally relevant phosphosites. While correlative analysis can clearly illuminate direct KS relationships in large-scale phosphorylation data, it can also provide functional information if one has a priori knowledge of the consequence of phosphorylation of one of the participating phosphosites. We exemplify this with the case of Slik and Stat92E. Phosphorylation of the Stat92E transcription factor at Tyr711 promotes DNA binding (Yan et al., 1996) . We found that phosphorylation at this particular site positively correlates with phosphorylation of Slik at Ser1376 ( Figure 5B ), suggestive of a relationship between Slik and Stat92E; the probability of observing two phosphosites correlating among six kinase-deficient profiles is rare (p = 1.4 3 10 À5 ). We predicted that Slik activates Stat92E
given that reduced Stat92E phosphorylation in slik-deficient embryos ( Figure 5C ) cannot be explained by instability of Stat92E protein ( Figure S5B ). Indeed, Stat92E target gene expression was downregulated in slik dsRNA-treated cells ( Figure 5D ). Insulin has been reported to enhance growth hormone-induced Stat activation in mature adipose cells (Zhang et al., 2013) , and Stat may be a direct target of the insulin receptor (Sawka-Verhelle et al., 1997). We confirmed an increase in the activating phosphorylation of Stat92E in cells treated with insulin ( Figure 5C ). Remarkably, we observed that more than a quarter of phosphoproteins downregulated in slik-deficient embryos are upregulated in cells in response to insulin, including Slik ( Figure 5C ; Figures S5E and S5F) . Moreover, 30% of phosphoproteins downregulated >1.3-fold in slik-deficient embryos (Table S7) were found to physically interact with components of the insulin-signaling network (Glatter et al., 2011) . These observations suggest that Slik could be activating Stat92E via insulin signaling. Consistent with this, we observed a reduction in activated Akt1 in slik-deficient embryos, despite elevated total Akt1 protein ( Figure 5E ). A reduction in insulin signaling may, in fact, explain the longevity of slik 1 mutant larvae (Hipfner and Cohen, 2003) . Raf interaction has been suggested to bridge Slik to the MAPK proliferation branch of cell survival signaling (Hipfner and Cohen, 2003), which our data support, as we find that 
Surveying Phosphorylation Networks in Drosophila slik-deficient embryos exhibit defects in ERK activation (Figure S5D) . Despite a nonessential role for slik in embryogenesis, our examination of correlative phosphorylation during this early stage illuminated Slik function, highlighting the power of our approach.
An Examination of Wee-Dependent Phosphorylation
We chose to examine more closely the phosphoproteomic profile of RNAi-derived wee kinase-deficient embryos, since their phenotype mirrored that reported for mutant wee embryos (Price et al., 2000) . Wee, Cdk1, and Aurora operate in a regulatory kinase cascade to control nuclear divisions in the early embryo. Phosphorylation and activation of Aurora by Cdk1 is inhibited by Wee and delays entry into mitosis. Wee inhibits Cdk1 by phosphorylating a conserved tyrosine (Tyr15) located in the ATP binding pocket (Campbell et al., 1995; Stumpff et al., 2004) . Therefore, we expected Cdk1 and Aurora to be hyperactive in the absence of Wee. Indeed, we find motif enrichment ( Figure 6A ) among 
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Surveying Phosphorylation Networks in Drosophila upregulated phosphosites in wee-deficient embryos that resembles Cdk and Aurora kinase consensus motifs (Cdk1: pS/T-P-X-K/R; pS/T-P-X-X-K and Aurora: R-R/K-pS/T; R/K-X-pS/T; R-R/ K-X-pS/T) (Alexander et al., 2011) . Accordingly, we consistently observed less TMT reporter ion signal proportionate to levels of Cdk1 Tyr15 phosphopeptides in wee-deficient embryos, implying Cdk1 hyperactivity in this context ( Figure 6B ). We corroborated this observation by immunoblotting with a Cdk1-pTyr15 antibody ( Figure S6A ). Significantly, we identified altered phosphorylation on half of those fly proteins whose orthologous yeast counterparts were identified as Cdk substrates ( Figure 6C ) (Holt et al., 2009) . Aurora is also hyperactive in wee-deficient embryos, reflected by the upregulation in phosphorylation of characterized targets: kinesin-like protein at 10A (Klp10A pSer210: 2.5-fold), inner centromere protein (Incenp pSer163: 1.5-fold and pSer164: 3-fold), and histone H3 (HH3 pSer10: 15-fold; pSer28: 7-fold) (Adams et al., 2001; Jang et al., 2009; Kang et al., 2001) . We verified HH3 phosphoalterations in wee-deficient embryos by immunoblotting ( Figure S6A) . Surprisingly, half of the upregulated phosphosites we identified in wee kinase-deficient embryos reside within sequence recognized by Cdk1 or downstream Aurora kinase ( Figure 6D ). This observation highlights the utility of phosphoproteomic signatures to reveal genetic epistasis. We also find enrichment for specific Gene Ontology Consortium categories for those phosphoproteins regulated by Wee ( Figure 6E ). As anticipated, we observed enrichment for cell cycle classified factors, particularly those with mitosis-specific functions such as nuclear migration, spindle organization, and chromosome segregation. Intriguingly, proteins with roles in chromatin assembly are overrepresented in our list of upregulated phosphoproteins in wee-deficient embryos. This is interesting, given the reported hypocondensation of mitotic chromatin in wee null embryos (Stumpff et al., 2004) . Motif enrichment among downregulated phosphorylations is illustrated ( Figure S6B ). Another indirect consequence of wee knockdown is the upregulation of Stat92E phosphorylation at Tyr711 in wee-deficient embryos (Table S5A) . Cdk1 has been shown to regulate Stat92E phosphorylation at Tyr711 in cells (Baeg et al., 2005) , and indeed, we detect elevated Y711-encompassing Stat92E phosphopeptides in wee-deficient embryos that cannot be attributed to increased Stat92E levels ( Figure S5B ). Wee functions as a conserved tyrosine kinase (Campbell et al., 1995; McGowan and Russell, 1993) ; therefore, we inquired as to whether any phosphoproteins for which tyrosine phosphorylation was reduced in wee-deficient embryos are, in fact, direct Wee targets. We cloned and tagged eight genes for expression in D. melanogaster cells, which were selected based on reduced phosphorylation (>1.5-fold) of the corresponding protein in wee-deficient embryos. Of these, we observed hemagglutinin (HA)-tagged Wee in immunoprecipitates of FLAGtagged Stonewall (Stwl: lane 6, Figure 7A ). In the reciprocal direction, we detected FLAG-tagged Klp10A, CG13605, Stwl, and Polychaetoid (Pyd) in immunoprecipitates of HA-Wee (Figure S6D) . Consistent with our observations, Pyd was previously identified in Wee-FLAG-HA immune complexes (Guruharsha et al., 2011). 
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We decided to focus on the nuclear protein Stwl, since the myb/SANT (Swi3, Ada2, N-CoR, TFIIB)-like domain it possesses has been found to influence histone modifications by modulating chromatin structure (Boyer et al., 2004) and wee mutant embryos have reported defects in chromatin condensation (Stumpff et al., 2004) . Like other heterochromatin regulators, Stwl influences position effect variegation and HH3 methylation in vivo (Maines et al., 2007; Yi et al., 2009) . We found that phosphopeptides encompassing Stwl Tyr305 were reduced in wee-deficient embryos ( Figure 6F ), despite total Stwl levels being elevated (lane 2 versus lane 1: Figure 7D ). These alterations in protein cannot be attributed to mRNA transcript stability ( Figure S6C ). Based on our observations that wee is required for Stwl-Tyr305 phosphorylation, we examined the effects of wee overexpression on Tyr phosphorylation of Stwl in cells. Tyr phosphorylation of Stwl is elevated in cells overexpressing wee, based on phospho-Tyr immunoprecipitation and detection by immunoblotting ( Figure 7B ). To ask if Wee can directly phosphorylate Stwl, we generated His-tagged Stwl-fusion proteins for in vitro kinase assays. We incubated purified His-Stwl fragments with human WEE1 (38% identity, 53% similarity to D. melanogaster Wee). WEE1 phosphorylated Stwl at multiple sites recognized by a phospho-Tyr antibody, including fragments encompassing Tyr305 ( Figure 7C, lanes 1 and 2) . Interestingly, the BESS domain-containing fragment consistently inhibited WEE1 kinase activity, as indicated by reduced WEE1 autophosphorylation, both as a His-tagged protein ( Figure 7C ) and as a glutathione S-transferase (GST)-tagged fusion protein (data not shown). The BESS motif is likely the region that interacts with Wee, given that this domain facilitates protein-protein interactions (Bhaskar and Courey, 2002) and is often found together with the myb/ SANT domain. The BESS motif of Suppressor of variegation 3-7 (Su(var)3-7) is required for its chromatin-silencing properties (Jaquet et al., 2006) . Like Su(var)3-7, Stwl influences trimethylation of HH3 at Lys9, in addition to Lys27 at larval stages (Yi et al., 2009) . We detected no obvious reduction in these repressive marks in stwl-depleted embryos. Rather, we observed alterations in trimethylated Lys4 of HH3, an activation mark (Figure 7E) . Consistent with a role for Wee in inhibiting Stwl activity, HH3 trimethyl Lys4 marks are elevated in wee-deficient embryos ( Figure 7E ). Effects of wee knockdown on Lys4 methylation in later stage 2-to 4-hr embryos was confounded by the inability of wee-deficient embryos to transit the MBT (data not shown). Based on our observations, we propose that Wee inhibits the ability of Stwl to modulate histone methylation prior to the MBT, halting the activation of zygotic transcription to regulate the timing of transit through the MBT.
DISCUSSION A Resource to Study Protein Kinases and Phosphatases in Early Embryos
We generated a validated collection of transgenic D. melanogaster shRNA lines targeting protein kinases and phosphatases maternally deposited in embryos. The collection permits the examination of zygotic lethal gene perturbations, without the effort of germline clone derivation. Multiple lines of evidence support that the embryonic phenotypes generated by our collection are, indeed, a result of shRNA on-targeting: (1) near-identical qualitative phenotypes generated by two unique shRNAs targeting the same gene for the 15% of the collection we tested; (2) abolition of shRNA-induced phenotypes by substitution of three nucleotides (C911s) precluding on-target binding; (3) the high degree of overlap between our shRNA-derived phenotypes and literature-reported mutant embryo and germline clone-derived embryo phenotypes; and (4) our general inability to accredit specific shRNA phenotypes to candidate OTEs derived from proteomics and partial complementarity matching.
A General Method to Predict Kinase Motifs and Targets
Using our shRNA collection, we performed quantitative phosphoproteome assessments of genetically compromised animals. An advantage of our gene knockdown strategy over gene knockout is that we restrict RNAi to the germline: since germline development is dispensable for organismal development, our RNAi method likely avoids major adaptation and compensation due to effects on the viability of the animal, such as that seen, for example, with yeast deletion mutants (Bodenmiller et al., 2010; Teng et al., 2013) . Additionally, the modest amount of transcription in early-stage embryos further minimizes the possibility of compensation at the transcriptional level, although nontranscriptional compensation is a possibility. Conceivably, by comparing genetic knockout to incomplete depletion by RNAi-mediated knockdown, one could identify compensatory rewiring events. From phosphoproteomic profiling of kinase-deficient embryos, we identified altered phosphorylation of characterized substrates of depleted kinases and generated an extensive list of candidate substrates of the depleted kinase and altered phosphoproteins targeted by downstream kinases. A challenge will be to distinguish between primary and secondary targets. It is difficult to evaluate the number of primary targets per kinase since this will depend on multiple factors, including the function of the kinase and its expression level, localization, and connectivity with other proteins. Indeed, studies from yeast and mammalian kinases have illustrated that the number of substrates for any one kinase can range from hundreds to only a few (Ubersax and Ferrell, 2007) . Thus, we expect variability in the number of substrates depending on the analyzed kinase. Furthermore, biologically meaningful alterations in phosphorylation may have been missed in our analyses, given the limitations of current mass spectrometry technology. We illustrate, however, that current instrumentation can be used to identify known and predicted targets relevant to the function of the perturbed kinase (e.g., Stwl is a direct target of Wee kinase) and so, despite perhaps only scratching the surface, we have generated biologically pertinent information. Additional information (e.g., in vitro kinase activity toward a substrate, protein-protein interaction, and functional assays) is necessary, of course, to infer a direct KS relationship (Sopko and Andrews, 2008) . Undoubtedly, extension of our methodology will be effective for systematically mapping substrates to culpable kinases and for pinpointing critical phosphosites important for substrate function.
Correlation and Anticorrelation: An Application for Network Analysis Our correlative analysis examining coordination between alterations in phosphosite pairs among kinase-deficient profiles
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Surveying Phosphorylation Networks in Drosophila uncovered signaling mechanisms. We demonstrate how a role for Slik kinase in regulating the transcription factor Stat92E could be predicted from correlative phosphorylation of these two proteins. The predictive power of this approach could be extended by knowing if specific phosphorylation events serve activating or inhibitory functions and by superimposing kinase consensus motifs. Our analysis demonstrates how functional phosphorylation might be uncovered in any phosphoproteomic data using simple correlative principles. Notably, predictions for any particular kinase can be made indirectly from its detection in varying genetic contexts, with no requirement for direct modulation of the queried kinase. The data we generated from embryos will complement orthogonal data sets such as kinase consensus motif and protein-protein interaction data derived from, for example, peptide and protein chip assays, coaffinity purifications, and yeast two-hybrid assays. Furthermore, phosphosite correlation information could be integrated with large-scale RNAi phenotype data in order to predict whether phosphorylation of a target by a specific kinase serves an activating or inhibiting function.
Perspective
Given that key signaling pathways and kinases implicated in human disease are conserved in Drosophila (Rubin et al., 2000) , the insight gained from our kinase-deficient phosphoproteomic signatures constitutes an important step toward understanding the kinome network. Going forward, we anticipate that phosphoproteomic assessment of other posttranslational modifications and more complex genotypes, using combinatorial knockdown (two shRNAs) or knockdown in combination with transgene overexpression or gain-of-function mutations, will appreciably illuminate our ability to decipher signaling mechanisms. In this way, global proteomic analyses could map pathways but also reveal critical nodes in signaling that may partially or completely overcome mutations resulting in pathway hyperactivity. Alternatively, phosphoproteomic assessment of a sensitized kinase mutant in the context of a substrate gain of function could expose altered signaling mechanisms contributing to compromised viability (Sopko et al., 2006) . Finally, genetic combinations would mimic more natural scenarios in terms of genetic heterogeneity contributing to susceptibility to disease and, by mapping contextual phosphorylation, would improve on our ability to predict and target essential signaling nodes.
EXPERIMENTAL PROCEDURES
Detailed methods are available in the Supplemental Experimental Procedures. Mass spectrometric sample preparation is further described in the Protocol.
Transgenic shRNA Line Generation shRNAs (21 base pairs) were cloned into VALIUM series vectors and injected into embryos for targeted phiC31-mediated integration at genomic attP landing sites on the second or third chromosome as described elsewhere (Ni et al., 2011) . All transgenic lines were sequenced to confirm the identity of the shRNA and miR-1 scaffold.
Protein Kinase or Phosphatase-Deficient Embryo Derivation
Females heterozygous for the UAS-shRNA and either MTD-Gal4 (Petrella et al., 2007) , expressing three versions of Gal4 sequentially throughout oogenesis, or tub-Gal4, a line expressing Gal4 from a maternal tubulin promoter at two insertion sites during mid-and late oogenesis (Staller et al., 2013) , were crossed to UAS-shRNA males to recover fertilized embryos.
RNA Isolation, Reverse Transcription, and Real-Time qPCR RNA was isolated by guanidinium thiocyanate-phenol-chloroform extraction using TRIzol (Life Technologies) and glass-bead-based cell disruption. Genomic DNA was eliminated by incubation with DNase (QIAGEN), and samples were processed for cleanup with an RNeasy MinElute Cleanup Kit (QIAGEN).
One microgram of purified RNA was incubated with a mix of oligo(dT) and random hexamer primers and with iScript RT (iScript cDNA Synthesis Kit, Bio-Rad) for complementary DNA (cDNA) synthesis. cDNA was used as the template for amplification, using validated primers in iQ SYBR Green Supermix with a CFX96 Real-Time PCR detection system (Bio-Rad). Query gene expression was relative to a control sample, normalized to the expression of three reference genes: ribosomal protein L32, alpha-tubulin, and either nuclear fallout or Gapdh1, using the DDC(t) analysis method.
Maternal Phenotype Derivation
Hatch rate was calculated from counting embryos 24 hr after deposition. For genotypes with defective hatching, cuticles prepared in Hoyer's mounting media were imaged with a Zeiss AxioCam HRC Camera mounted on a Zeiss Axiophot microscope.
Coimmunoprecipitation and Immunoblotting
Lysates were subjected to immunoprecipitation using the indicated antibodies, and samples were subjected to SDS-PAGE followed by immunoblotting.
Quantitative Phosphoproteomics
Embryos lysed in 8 M urea were digested with trypsin, and peptides were chemically labeled with one of six TMT Isobaric Mass Tags (Thermo Fisher Scientific), separated into 12 fractions by strong cation exchange chromatography, purified with TiO 2 microspheres, and analyzed via liquid chromatography-tandem mass spectrometry on an Orbitrap Velos Pro mass spectrometer (Thermo Fisher Scientific). Peptides were identified by Sequest and filtered to a 1% peptide false discovery rate (FDR). Proteins were filtered to achieve a 2% final protein FDR (final peptide FDR near 0.15%). TMT reporter ion intensities for individual phosphopeptides were normalized to the summed reporter ion intensity for each TMT label. The localizations of phosphorylations were assigned using the AScore algorithm.
In Vitro Kinase Assay
In vitro kinase assays were carried out as described elsewhere (Sopko et al., 2006) .
Correlative Analysis
A phosphosite matrix was constructed where rows correspond to identified phosphosites and columns correspond to kinase-deficient data sets. Only phosphosites with R0.58 log 2 -fold change were distinguished, by values +1 and À1, based on an increase or decrease, respectively, in levels relative to an shRNA control. All pairwise combinations of phosphosites were classified as positive or negative correlating based on their change in the same or opposite direction, respectively, for each kinase-deficient condition. A correlation sign score was determined, considering the number of positive and negative correlations and the total number of kinase-deficient phosphorylation profiles where both phosphosites change. 
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Figure S2, Related to Figures 2 and 3
Characterization of the transgenic protein kinase and phosphatase shRNA collection.
(A) Plotted is the cumulative number of lines in the collection capable of achieving a particular extent of knockdown in early embryos with a germline specific Gal4 driver. The number of transgenic lines capable of generating that specific degree of knockdown or better is indicated next to each data point.
Lines that fail to generate eggs are not included.
(B) Based on qPCR analysis of embryos derived from the germline of females expressing a distinct shRNA, at least one of two shRNAs targeting the same protein kinase or phosphatase will generate 60% knockdown or better for the corresponding gene at a frequency of 86% (N=81).
(C) Considering those shRNAs that unambiguously target the coding sequence (CDS), or the 5' or 3' untranslated region (UTR) of all transcript isoforms, we find shRNA design influences knockdown.
81% of lines expressing an shRNA targeting the CDS generated greater than 60% knockdown, while only 14% of lines expressing an shRNA targeting the 3'UTR generated greater than 60% knockdown -annotated as 'success'. The numbers of lines considered are indicated in parentheses. Plotted (yaxis) is the average transcript level (based on two independent qPCR measurements) remaining in 0-4 hour old embryos derived from females subjected to specific shRNA expression, relative to an shRNA targeting EGFP, versus (x-axis): (D) the average transcript level (units in RPKM) derived from two time points encompassing the same developmental time (Graveley et al., 2011) ; (E) the concentration of purified RNA used for the corresponding qPCR measurement; and (F) the batch date of processing. Three reference genes were used for normalization. Characterization of wee deficient embryos.
(A) Lysates from 0-4 hour embryos derived from females expressing an shRNA targeting wee and a white control shRNA were analyzed by immunoblotting with anti-Cdk1-pTyr15, anti-HH3-pSer10 and anti-HH3-pSer28 antibodies. Immunoblotting with anti-tubulin and anti-HH3 serve as loading controls.
(B)
Approximately 6400 phosphosites identified in wee deficient embryonic lysates were ranked according to degree of change relative to control. Indicated are motifs encompassing phosphosites that are enriched among those phosphosites downregulated >1.5 fold. Motif-X was used to identify motifs (Chou and Schwartz, 2011) . The PLogo tool was used to generate motif logos. Favored amino acids at corresponding positions are indicated above the line while disfavored amino acids are below.
(C) Plotted (y-axis) is the transcript level of stwl and wee remaining in 0-4hr old embryos derived from the germline of females subjected to specific shRNA expression, relative to an shRNA targeting EGFP. Three reference genes were used for normalization.
(D) Lysates from Drosophila cells expressing HA-tagged Wee together with 3xFLAG-tagged candidate Wee substrates were subjected to immunoprecipitation with anti-HA antibody and analyzed by immunoblotting with the indicated antibodies. Transgenic shRNA line generation was essentially as described (Ni et al., 2011) . Twenty-one base pair shRNAs were cloned into either VALIUM20 or VALIUM22 and injected for targeted phiC31-mediated integration (Groth et al., 2004; Thomason et al., 2001 ) at genomic attP landing sites:
Supplemental Tables
P{CaryP}attP2 (3L: 68A4) or P{CaryP}attP40 (2L: 25C6 
Transcript knockdown assessment in shRNA-expressing embryos
Germline-specific expression of shRNAs targeting EGFP (control) or various protein kinases and phosphatases was induced using the Gal4-UAS system (Brand and Perrimon, 1993) . Specifically, 70
females heterozygous for the UAS-shRNA and either MTD-Gal4 (Petrella et al., 2007) , a line expressing three Gal4 drivers sequentially throughout oogenesis, or tub-Gal4, a line expressing Gal4 from a maternal tubulin promoter at two insertion sites during mid and late oogenesis (Staller et al., 2013) , were crossed to 40 UAS-shRNA males to recover fertilized embryos. RNA was isolated as described above, from approximately 250 embryos (0-4 hour old) derived from Gal4/shRNA females cultured at 27 0 C. cDNA was synthesized from 1 microgram of purified RNA as indicated above. cDNA synthesis and quantitative real time PCR analysis was carried out twice, with technical triplicates, using validated primers in iQ SYBR Green Supermix (Bio-Rad), with a CFX96 Real-Time PCR detection system (Bio-Rad). Query gene expression was relative to a control sample, normalized to the expression of three reference genes: ribosomal protein L32, alpha-tubulin, and either nuclear fallout or Gapdh1, using the C(t) analysis method. These reference genes range in expression from high to low in 0-4 hour embryos, based on RNA-Seq data (Graveley et al., 2011) . The extent of knockdown is reported as 1) an average of the remaining transcript relative to two independent reference genes; and 2) a single remaining transcript value derived from comparison to the reference gene for which the control sample and the knockdown sample are closest in terms of cycle threshold (Ct) value for that specific reference gene (the preferred method).
Stat92E target gene expression in slik shRNA and EGFP shRNA-expressing embryos cDNA was synthesized from 1 microgram of RNA purified from slik shRNA and EGFP shRNAexpressing embryos as described above. Quantitative real time PCR analysis was carried out with technical triplicates using validated primers (Rajan and Perrimon, 2013) in iQ SYBR Green Supermix (Bio-Rad), with a CFX96 Real-Time PCR detection system (Bio-Rad). Query transcript detection was normalized to the expression of the reference gene ribosomal protein L32.
Immunoblotting of embryos
Embryos were collected and incubated in 50% bleach for 5 minutes. Post washing with 0.1% TritonX-100, an equal volume of 2x SDS loading buffer was added to the dechorionated embryos in an Eppendorf Safe-Lock 1.5ml microcentrifuge tube. 
Embryo preparation for mass spectrometric analysis
Eggs were collected, dechorionated with 50% bleach for 5 minutes, washed with 0.1% Triton X-100, sorted under the microscope to remove any contaminating aged embryos, and delivered to denaturing urea buffer for lysis. Embryos were lysed with a glass homogenizer on ice in: 8M urea, 75mM sodium chloride, 50mM Reactions were quenched by the addition of hydroxylamine to 0.3% and incubation at room temperature for 15 minutes. Labeled peptides were combined, lyophilized, and stored at -80°C until further processing. Samples were acidified with 10% trifluoroacetic acid and desalted using a 3cc
Sep-Pak tC18 solid-phase extraction cartridge (Waters). Phosphopeptides were separated by strong cation exchange chromatography (SCX: . Lyophilized peptides were resuspended in SCX buffer A (7mM potassium phosphate, pH 2.65, 30% acetonitrile) and injected onto a SCX column (Polysulfoethyl aspartamide, 9.4 mm×250mm, 5 uM particle size, 200 Ǻ pore size, PolyLC). A gradient was developed over 35 min from 0% to 30% buffer B (7mM potassium phosphate, pH 2.65, 30% acetonitrile, 350mM potassium chloride) at a flow rate of 2.5 ml/min. Twelve fractions were collected and lyophilized. Peptides were then desalted with 1cc Waters Sep-Pak tC18
solid-phase extraction cartridges and subjected to titanium dioxide based phosphopeptide enrichment (Kettenbach and Gerber, 2011) using 500 micrograms titanium dioxide microspheres (GL Sciences)
per milligram protein. Eluates were further desalted using STAGE tips (Rappsilber et al., 2003) and lyophilized. Samples were reconstituted in 5% formic acid / 5% acetonitrile.
For shotgun mass spectrometry, 1 milligram of protein was alkylated and digested peptides were subjected to SCX fractionation into twenty fractions without labeling and desalted eluates lyophilized and reconstituted in 5% formic acid / 5% acetonitrile. 
Preparation of Drosophila cells for mass spectrometric analysis
Mass spectrometric analysis
Ratio distortion in isobaric quantitative proteomic experiments is a major concern due to interference by contaminating ions in the isolation envelope subjected to MS/MS (Ting et al., 2011) . We reasoned interference should be less of an issue with phospho-enriched samples: we anticipated 4 phosphopeptides to be isolated for each protein (4x 6,980 = 27,920 phosphopeptides) based on the average number of phosphosites per protein found to date in yeast (Amoutzias et al., 2012) . The predicted number of peptides generated by digestion of the D. melanogaster proteome with trypsin is 321,297 (Brunner et al., 2007) . We therefore estimated a phospho-enriched mixture would have approximately 10-fold reduced complexity compared to the entire proteome, thus justifying our rationale for proceeding with MS/MS-based analysis. Moreover, the 12% reduction in protein quantifications observed with an alternative MS 3 method (Ting et al., 2011) would translate to an even greater loss for phosphopeptide quantifications given that individual protein quantifications are an average of many peptide measurements while phosphopeptide quantifications are derived from a single measurement. For these reasons we decided to proceed with MS/MS based analyses.
Samples were subjected to LC-MS/MS with an Orbitrap Velos Pro mass spectrometer (Thermo Scientific) using higher energy collision dissociation (HCD: (Olsen et al., 2007) and a top ten method (Dephoure et al., 2008) . MS/MS spectra were searched against a composite database of D.
melanogaster proteins derived from Flybase version 5.23 in both the forward and reverse orientation using the Sequest algorithm (Eng, 1994 (Elias and Gygi, 2007) enabled thresholding of the false discovery rate (FDR) for MS/MS spectral assignment at 1%. Correct spectral matches were distinguished from incorrect matches using linear discriminant analysis based on parameters including Xcorr, ΔCn, precursor mass error, peptide length, and charge state (Huttlin et al., 2010) . The localizations of individual phosphorylations were assigned using the probability-based AScore algorithm (Beausoleil et al., 2006) and only phosphosites with AScores greater than 13 (p < 0.05) were considered in our analysis. Moreover, only phosphopeptides with isolation specificity greater than 0.75 were considered for further analysis. Further filtering of the dataset resulted in a final protein FDR of ~2% and a peptide FDR near 0.15%. TMT labeling was >98% efficient. For TMT reporter ion quantification, a 0.03 Da window centered on the expected mass of each reporter ion was monitored and the intensity of the signal closest to the expected mass was recorded. Reporter ion signals were further adjusted to correct for impurities associated with each TMT label, as described elsewhere (McAlister et al., 2012) . Raw TMT reporter ion intensities for individual phosphopeptides were normalized to the summed reporter ion intensity for each TMT label. Adjusted reporter ion intensities were averaged between replicates. Only phosphopeptides for which the summed signal intensity, corrected for noise, among all channels was equal to or greater than 100 were considered. Further, phosphopeptide consideration required signal detection in a least five of six TMT channels for single genotype experiments, and four of six TMT channels for experiments with duplicate samples. Peptides generating detectable TMT reporter ions in only one replicate sample were excluded. A website to query proteins and view identified phosphosites and their levels in kinase-deficient conditions can be found at http://www.flyrnai.org/PhosphoSite.html. Proteomics data have been submitted to the PRIDE Archive repository via ProteomeXchange.
Maternal phenotype derivation
In order to examine maternal phenotypes, 10 maternal-GAL4>UAS-shRNA females, derived from a cross between maternal-GAL4 females and UAS-shRNA bearing males, were crossed to 5 UASshRNA males and embryos collected at 27 0 C. Hatch rate was calculated based on the ratio of hatched to unhatched embryos, from counting approximately one hundred embryos twenty-four hours after egg deposition. For those genotypes with defective hatching, cuticles were prepared to examine patterning defects using Hoyer's mounting media. Imaging was with a Zeiss Axiophot microscope mounted with a Zeiss AxioCam HRC Camera.
Co-immunoprecipitations
Drosophila cells transfected (Qiagen Effectene Transfection Reagent) with pAHW-Wee together with candidate Wee substrates in pAFW or pAWF were lysed in TNTE lysis buffer (50mM Tris-HCl pH 7.4, 150mM sodium chloride, 1mM EDTA, 0.5% Triton X-100, 1mM sodium fluoride, 1mM -glycerophosphate, 1mM sodium orthovanadate, 10mM sodium pyrophosphate, 1mM PMSF, EDTAfree Protease Inhibitor Cocktail Tablet (Roche) on ice. Clarified lysates were subjected to immunoprecipitation for 2 hours with anti-FLAG antibody (Sigma F3165) and Protein G Sepharose 
Transcript knockdown assessment in cells
Drosophila S2R+ cells were cultured in in Schneider's Medium (Gibco) supplemented with Fetal Bovine Serum (FBS) (final concentration of 10%), Penicillin (50 units/milliliter final concentration), and Streptomycin (50 micrograms/milliliter final concentration). All dsRNA experiments were performed using the bathing method described at www.flyrnai.org. Briefly, S2R+ cells were re-suspended and diluted in serum free medium before seeding with dsRNAs targeting slik (DRSC37061) or EGFP.
After 30 minutes incubation, complete medium with FBS was added. Cells were harvested following four days of RNAi. Reactions were stopped by addition of 2x sample buffer. Samples were resolved by SDS-PAGE and analyzed by immunoblotting with anti-pTyr (Cell Signaling #9416).
In vitro kinase assay
Correlative analysis
Correlative analysis was adapted from (Vinayagam et al., 2013) . Briefly, for each phosphosite in a kinase-deficient phosphorylation profile we computed a log2 fold-change value compared to the white shRNA control. The phosphosites with significant increase (≥ 0.58 log2 fold change) or decrease (≤ -0.58 log2 fold change) were distinguished with values +1 and -1 respectively.
Phosphosites that did not show significant change (-0.585 > x < 0.585) were assigned a value of zero. We constructed a phosphosite matrix by combining multiple kinase-deficient phosphorylation profiles, where the rows correspond to phosphosites and columns correspond to the kinase-deficient datasets. Next, we analyzed all pair-wise combinations of phosphosites to compute the correlation.
In a given dataset, if both phosphosites have non-zero values, then the relationship is classified as either positive correlation (both +1 or both -1) or negative correlation (one is +1 and the other is -1).
For each pair of phosphosites, we computed the total number of positive and negative correlations.
Then we used a simple model to calculate a correlation sign score (CSscore) for each pair of phosphosites as follows:
√ , corresponds to the number of positive and negative correlations, respectively. is the total number of kinase-deficient phosphorylation profiles where both phosphosites show significant change ( + ). Note that should be ≥ 2 in order to be considered for correlation analysis. √Tp is the weight factor to assign more confidence for sign correlations predicted based on a larger number of kinase-deficient data. If a score has a positive value (CSscore ≥ 1) then the pair is primarily positive correlated, if the score has negative value (CSscore ≤ -1) then the pair is primarily negatively correlated. The significance of overlap between the correlation network and the reference networks (NetPhorest and Yeast Gold Standard set) was computed using the random overlap (RD), estimated from random correlation networks. To generate a random correlation network the phosphosite matrix was randomized, where the phosphosite signatures are preserved but the phosphosites (IDs) are randomly permuted. Note that we preserved the same number of correlations for kinase phosphosites. Mean and standard deviation of RD is computed from 1,000 simulations of random networks. The p-value is computed by modeling the RD distribution as a Gaussian distribution.
Partial Complementarity Matching of shRNAs
In order to evaluate off-target effects caused by seed-region matches of shRNA reagents, we: 1) extracted the seed sequences of each shRNA reagent, defined as the seven nucleotide sequence between positions 2-8 on anti-sense strand; 2) compared the shRNA seed sequences with the 3UTR or full transcript sequences of genes encoding phosphoproteins downregulated in corresponding shRNA-expressing embryos, considering different levels of confidence; and 3) calculated enrichment P-values based on hyper-geometric distribution. The analysis indicates that the likelihood of phosphoprotein downregulation as a result of transcript degradation due to targeting of the corresponding transcript by the shRNA reagent itself is small is most cases (P-values > 1).
Specifically, as the number of downregulated phosphosites for any one protein increases (compare Type 2 and Type 3 phosphoproteins: majority versus all identified phosphosites downregulated respectively), the less likely are off-target effects due to seed-region matches.
